应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
ENSC Ensysce Biosciences Inc.
交易中 11-22 11:50:44 EST
0.4858
-0.1066
-17.99%
最高
0.5600
最低
0.4418
成交量
197.19万
今开
0.5600
昨收
0.5924
日振幅
19.95%
总市值
950.91万
流通市值
807.55万
总股本
1,957万
成交额
98.84万
换手率
11.86%
流通股本
1,662万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Ensysce Biosciences, Inc.盘中异动 早盘股价大跌7.16%报0.550美元
市场透视 · 11-22 22:31
Ensysce Biosciences, Inc.盘中异动 早盘股价大跌7.16%报0.550美元
Ensysce Biosciences, Inc.盘中异动 急速下跌5.29%报0.621美元
市场透视 · 11-21 23:14
Ensysce Biosciences, Inc.盘中异动 急速下跌5.29%报0.621美元
Ensysce Biosciences, Inc.盘中异动 下午盘快速下跌5.22%报0.642美元
市场透视 · 11-21 02:29
Ensysce Biosciences, Inc.盘中异动 下午盘快速下跌5.22%报0.642美元
Ensysce Biosciences, Inc.盘中异动 早盘快速上涨5.15%
市场透视 · 11-19
Ensysce Biosciences, Inc.盘中异动 早盘快速上涨5.15%
Ensysce Biosciences, Inc.盘中异动 股价大涨5.91%
市场透视 · 11-19
Ensysce Biosciences, Inc.盘中异动 股价大涨5.91%
Ensysce Biosciences Inc 报告截至 9 月 30 日的季度业绩 - 收益摘要
路透中文 · 11-16
Ensysce Biosciences Inc 报告截至 9 月 30 日的季度业绩 - 收益摘要
Ensysce Biosciences, Inc.盘中异动 早盘股价大跌5.19%
市场透视 · 11-14
Ensysce Biosciences, Inc.盘中异动 早盘股价大跌5.19%
Ensysce Biosciences, Inc.股价拉升16.59% 市值涨194.6万美元
市场透视 · 11-13
Ensysce Biosciences, Inc.股价拉升16.59% 市值涨194.6万美元
Ensysce Biosciences, Inc.盘中异动 快速跳水6.70%
市场透视 · 11-11
Ensysce Biosciences, Inc.盘中异动 快速跳水6.70%
Ensysce Biosciences, Inc.盘中异动 早盘急速下挫5.06%
市场透视 · 11-08
Ensysce Biosciences, Inc.盘中异动 早盘急速下挫5.06%
Ensysce Biosciences, Inc.盘中异动 急速跳水6.67%
市场透视 · 11-05
Ensysce Biosciences, Inc.盘中异动 急速跳水6.67%
Ensysce Biosciences, Inc.盘中异动 早盘股价大涨10.75%报0.720美元
市场透视 · 11-04
Ensysce Biosciences, Inc.盘中异动 早盘股价大涨10.75%报0.720美元
Ensysce Biosciences, Inc.盘中异动 股价大涨5.03%
市场透视 · 11-01
Ensysce Biosciences, Inc.盘中异动 股价大涨5.03%
Ensysce Biosciences, Inc.盘中异动 早盘大幅下跌12.72%
市场透视 · 10-31
Ensysce Biosciences, Inc.盘中异动 早盘大幅下跌12.72%
Ensysce Biosciences, Inc.盘中异动 股价大涨5.17%报0.350美元
市场透视 · 10-30
Ensysce Biosciences, Inc.盘中异动 股价大涨5.17%报0.350美元
Ensysce Biosciences, Inc.盘中异动 早盘股价大涨5.34%
市场透视 · 10-28
Ensysce Biosciences, Inc.盘中异动 早盘股价大涨5.34%
Ensysce Biosciences, Inc.盘中异动 早盘快速上涨5.24%报0.332美元
市场透视 · 10-25
Ensysce Biosciences, Inc.盘中异动 早盘快速上涨5.24%报0.332美元
Ensysce Biosciences, Inc.盘中异动 早盘股价大跌6.68%报0.374美元
市场透视 · 10-24
Ensysce Biosciences, Inc.盘中异动 早盘股价大跌6.68%报0.374美元
Ensysce Biosciences, Inc.股价重挫22.08% 市值跌128.64万美元
市场透视 · 10-23
Ensysce Biosciences, Inc.股价重挫22.08% 市值跌128.64万美元
Ensysce Biosciences, Inc.股价上涨155.92% 市值涨1140.24万美元
市场透视 · 10-22
Ensysce Biosciences, Inc.股价上涨155.92% 市值涨1140.24万美元
加载更多
公司概况
公司名称:
Ensysce Biosciences Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Ensysce Biosciences, Inc.于2003年4月在特拉华州注册成立。该公司是一家临床阶段的生物技术公司,利用其专有技术平台开发更安全的处方药。利用其胰蛋白酶激活滥用保护和多药滥用抗性平台,该公司正在开发一类新的强大、防篡改的阿片类药物,可防止药物滥用和过量服用。预计Ensysce的产品将提供更安全的选择来治疗严重的疼痛,并有助于预防阿片类药物滥用造成的死亡,从而降低人力和经济成本。
发行价格:
--
{"stockData":{"symbol":"ENSC","market":"US","secType":"STK","nameCN":"Ensysce Biosciences Inc.","latestPrice":0.4858,"timestamp":1732294243184,"preClose":0.5924,"halted":0,"volume":1971884,"delay":0,"floatShares":16623100,"shares":19574014,"eps":-1.221087,"marketStatus":"交易中","marketStatusCode":2,"change":-0.1066,"latestTime":"11-22 11:50:44 EST","open":0.56,"high":0.56,"low":0.4418,"amount":988368.2060736,"amplitude":0.199527,"askPrice":0.4898,"askSize":12,"bidPrice":0.4832,"bidSize":100,"shortable":0,"etf":0,"ttmEps":-1.221087,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1732309200000},"adr":0,"adjPreClose":0.5924,"preHourTrading":{"tag":"盘前","latestPrice":0.563,"preClose":0.5924,"latestTime":"09:29 EST","volume":62378,"amount":34998.12878828,"timestamp":1732285761267},"postHourTrading":{"tag":"盘后","latestPrice":0.579,"preClose":0.5924,"latestTime":"19:58 EST","volume":84895,"amount":48743.30205,"timestamp":1732237120083},"volumeRatio":2.607336,"impliedVol":3.1521,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/ENSC","defaultTab":"news","newsList":[{"id":"2485261509","title":"Ensysce Biosciences, Inc.盘中异动 早盘股价大跌7.16%报0.550美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485261509","media":"市场透视","labels":["Business Data"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485261509?lang=zh_cn&edition=full","pubTime":"2024-11-22 22:31","pubTimestamp":1732285917,"startTime":"0","endTime":"0","summary":"北京时间2024年11月22日22时31分,Ensysce Biosciences, Inc.股票出现异动,股价快速下挫7.16%。截至发稿,该股报0.550美元/股,成交量16.8091万股,换手率0.86%,振幅1.69%。Ensysce Biosciences, Inc.股票所在的生物技术行业中,整体涨幅为0.37%。Ensysce Biosciences, Inc.公司简介:Ensysce Biosciences Inc 是一家临床阶段的生物技术公司,利用其专有技术平台开发更安全的处方药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122223157abd79211&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122223157abd79211&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"Business Data","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","VRPX","ENSC","BK4139"],"gpt_icon":0},{"id":"2485904413","title":"Ensysce Biosciences, Inc.盘中异动 急速下跌5.29%报0.621美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485904413","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485904413?lang=zh_cn&edition=full","pubTime":"2024-11-21 23:14","pubTimestamp":1732202088,"startTime":"0","endTime":"0","summary":"北京时间2024年11月21日23时14分,Ensysce Biosciences, Inc.股票出现波动,股价急速跳水5.29%。截至发稿,该股报0.621美元/股,成交量32.4845万股,换手率1.66%,振幅4.87%。Ensysce Biosciences, Inc.股票所在的生物技术行业中,整体跌幅为0.38%。Ensysce Biosciences, Inc.公司简介:Ensysce Biosciences Inc 是一家临床阶段的生物技术公司,利用其专有技术平台开发更安全的处方药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112123144898e43f27&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112123144898e43f27&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ENSC"],"gpt_icon":0},{"id":"2485126496","title":"Ensysce Biosciences, Inc.盘中异动 下午盘快速下跌5.22%报0.642美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485126496","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485126496?lang=zh_cn&edition=full","pubTime":"2024-11-21 02:29","pubTimestamp":1732127373,"startTime":"0","endTime":"0","summary":"北京时间2024年11月21日02时29分,Ensysce Biosciences, Inc.股票出现波动,股价快速跳水5.22%。Ensysce Biosciences, Inc.股票所在的生物技术行业中,整体涨幅为0.45%。其相关个股中,Forte Biosciences, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Nls Pharmaceutics Ltd C/Wts 02/02/2026涨幅较大,Forte Biosciences, Inc.、Silexion Therapeutics Corp、Exicure, Inc.较为活跃,换手率分别为1759.87%、1258.51%、923.59%,振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Forte Biosciences, Inc.、Exicure, Inc.,振幅分别为185.64%、169.09%、136.94%。Ensysce Biosciences, Inc.公司简介:Ensysce Biosciences Inc 是一家临床阶段的生物技术公司,利用其专有技术平台开发更安全的处方药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121022933a24929bc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121022933a24929bc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ENSC"],"gpt_icon":0},{"id":"2484256179","title":"Ensysce Biosciences, Inc.盘中异动 早盘快速上涨5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484256179","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484256179?lang=zh_cn&edition=full","pubTime":"2024-11-19 23:00","pubTimestamp":1732028423,"startTime":"0","endTime":"0","summary":"北京时间2024年11月19日23时00分,Ensysce Biosciences, Inc.股票出现波动,股价快速上涨5.15%。Ensysce Biosciences, Inc.股票所在的生物技术行业中,整体跌幅为1.04%。其相关个股中,Psyence Biomedical Ltd C/Wts 25/01/2029、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Dermata Therapeutics Inc C/Wts 涨幅较大,Tff Pharmaceuticals, Inc.、Hcw Biologics Inc.、Exicure, Inc.较为活跃,换手率分别为684.94%、91.83%、76.29%,振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Klotho Neurosciences Inc C/Wts 21/06/2029 、Tff Pharmaceuticals, Inc.,振幅分别为81.67%、52.14%、45.03%。Ensysce Biosciences, Inc.公司简介:Ensysce Biosciences Inc 是一家临床阶段的生物技术公司,利用其专有技术平台开发更安全的处方药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119230023971a772f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119230023971a772f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ENSC","BK4139"],"gpt_icon":0},{"id":"2484604648","title":"Ensysce Biosciences, Inc.盘中异动 股价大涨5.91%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484604648","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484604648?lang=zh_cn&edition=full","pubTime":"2024-11-19 02:17","pubTimestamp":1731953832,"startTime":"0","endTime":"0","summary":"北京时间2024年11月19日02时17分,Ensysce Biosciences, Inc.股票出现异动,股价大幅拉升5.91%。Ensysce Biosciences, Inc.股票所在的生物技术行业中,整体跌幅为0.01%。其相关个股中,Hcw Biologics Inc.、冠科美博、Apollomics Inc C/Wts 01/04/2028 涨幅较大,Hcw Biologics Inc.、冠科美博、Tharimmune, Inc.较为活跃,换手率分别为1160.66%、1098.62%、566.76%,振幅较大的相关个股有Hcw Biologics Inc.、冠科美博、Apollomics Inc C/Wts 01/04/2028 ,振幅分别为563.48%、221.58%、193.44%。Ensysce Biosciences, Inc.公司简介:Ensysce Biosciences Inc 是一家临床阶段的生物技术公司,利用其专有技术平台开发更安全的处方药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111902171298e4352a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111902171298e4352a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ENSC"],"gpt_icon":0},{"id":"2483453610","title":"Ensysce Biosciences Inc 报告截至 9 月 30 日的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2483453610","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483453610?lang=zh_cn&edition=full","pubTime":"2024-11-16 06:00","pubTimestamp":1731708054,"startTime":"0","endTime":"0","summary":"Ensysce Biosciences Inc 报告截至 9 月 30 日的季度业绩 - 收益摘要Ensysce Biosciences Inc ENSC.OQ报告了截至9月30日的季度调整后每股收益7美分,高于去年同期的每股收益-87美分。Ensysce Biosciences Inc 公布的本季度每股收益为 7 美分。公司报告的季度净收入为 66.2 万美元。Ensysce Biosciences Inc 的股价本季度上涨了 164.9%,今年到目前为止下跌了 40.0%。建议华尔街对 Ensysce Biosciences Inc 的 12 个月目标价中位数为 8.30 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241115:nL4T3MM1K7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ENSC"],"gpt_icon":0},{"id":"2483043718","title":"Ensysce Biosciences, Inc.盘中异动 早盘股价大跌5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483043718","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483043718?lang=zh_cn&edition=full","pubTime":"2024-11-14 22:31","pubTimestamp":1731594686,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日22时31分,Ensysce Biosciences, Inc.股票出现异动,股价快速下跌5.19%。Ensysce Biosciences, Inc.股票所在的生物技术行业中,整体跌幅为0.42%。其相关个股中,Elevai Labs, Inc.、Cardio Diagnostics Holdings Inc C/Wts To Pur Com、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大,Elevai Labs, Inc.、Calidi Biotherapeutics, Inc.、Cyclacel Pharmaceuticals, Inc.较为活跃,换手率分别为1403.84%、19.59%、11.31%,振幅较大的相关个股有Pulmatrix, Inc.、Cargo Therapeutics, Inc.、Heron Therapeutics, Inc.,振幅分别为9.83%、8.67%、8.60%。Ensysce Biosciences, Inc.公司简介:Ensysce Biosciences Inc 是一家临床阶段的生物技术公司,利用其专有技术平台开发更安全的处方药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111422312698e42a08&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111422312698e42a08&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ENSC","BK4139"],"gpt_icon":0},{"id":"2483881112","title":"Ensysce Biosciences, Inc.股价拉升16.59% 市值涨194.6万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483881112","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483881112?lang=zh_cn&edition=full","pubTime":"2024-11-13 22:31","pubTimestamp":1731508267,"startTime":"0","endTime":"0","summary":"北京时间2024年11月13日22时31分,Ensysce Biosciences, Inc.股票出现波动,股价急速上涨16.59%。Ensysce Biosciences, Inc.股票所在的生物技术行业中,整体涨幅为0.05%。其相关个股中,Celularity Inc C/Wts 16/07/2026 、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Kairos Pharma, Ltd.涨幅较大,Cyclacel Pharmaceuticals, Inc.、Elevai Labs, Inc.、Tharimmune, Inc.较为活跃,换手率分别为325.52%、170.28%、84.06%,振幅较大的相关个股有Entero Therapeutics Inc.、Kairos Pharma, Ltd.、Turnstone Biologics Corp.,振幅分别为8.29%、7.79%、7.65%。Ensysce Biosciences, Inc.公司简介:Ensysce Biosciences Inc 是一家临床阶段的生物技术公司,利用其专有技术平台开发更安全的处方药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111322310795be2304&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111322310795be2304&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ENSC","BK4139"],"gpt_icon":0},{"id":"2482573852","title":"Ensysce Biosciences, Inc.盘中异动 快速跳水6.70%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482573852","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482573852?lang=zh_cn&edition=full","pubTime":"2024-11-11 22:32","pubTimestamp":1731335561,"startTime":"0","endTime":"0","summary":"北京时间2024年11月11日22时32分,Ensysce Biosciences, Inc.股票出现波动,股价大幅下挫6.70%。Ensysce Biosciences, Inc.股票所在的生物技术行业中,整体跌幅为0.13%。其相关个股中,Cero Therapeutics Holdings, Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 涨幅较大,Revelation Biosciences, Inc.、Cero Therapeutics Holdings, Inc.、Elevai Labs, Inc.较为活跃,换手率分别为410.97%、133.96%、66.65%,振幅较大的相关个股有Cero Therapeutics Holdings, Inc.、Aptevo Therapeutics Inc.、Eupraxia Pharmaceuticals Inc.,振幅分别为32.57%、10.27%、10.20%。Ensysce Biosciences, Inc.公司简介:Ensysce Biosciences Inc 是一家临床阶段的生物技术公司,利用其专有技术平台开发更安全的处方药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111122324198e41c5c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111122324198e41c5c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ENSC","BK4139"],"gpt_icon":0},{"id":"2481101902","title":"Ensysce Biosciences, Inc.盘中异动 早盘急速下挫5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481101902","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481101902?lang=zh_cn&edition=full","pubTime":"2024-11-08 22:30","pubTimestamp":1731076249,"startTime":"0","endTime":"0","summary":"北京时间2024年11月08日22时30分,Ensysce Biosciences, Inc.股票出现异动,股价急速下跌5.06%。Ensysce Biosciences, Inc.股票所在的生物技术行业中,整体涨幅为0.00%。其相关个股中,Fortrea Holdings Inc.、Tenaya Therapeutics, Inc.、Anebulo Pharmaceuticals, Inc.涨幅较大,Elevai Labs, Inc.、Matinas Biopharma Holdings, Inc.、Lipella Pharmaceuticals Inc.较为活跃,换手率分别为356.28%、16.21%、13.30%,振幅较大的相关个股有Anebulo Pharmaceuticals, Inc.、Scorpius Holdings, Inc.、Tevogen Bio Holdings Inc.,振幅分别为14.96%、5.33%、4.39%。Ensysce Biosciences, Inc.公司简介:Ensysce Biosciences Inc 是一家临床阶段的生物技术公司,利用其专有技术平台开发更安全的处方药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110822304998e41764&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110822304998e41764&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ENSC","BK4139"],"gpt_icon":0},{"id":"2481268898","title":"Ensysce Biosciences, Inc.盘中异动 急速跳水6.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481268898","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481268898?lang=zh_cn&edition=full","pubTime":"2024-11-05 22:34","pubTimestamp":1730817269,"startTime":"0","endTime":"0","summary":"北京时间2024年11月05日22时34分,Ensysce Biosciences, Inc.股票出现异动,股价急速跳水6.67%。Ensysce Biosciences, Inc.股票所在的生物技术行业中,整体涨幅为0.01%。Ensysce Biosciences, Inc.公司简介:Ensysce Biosciences Inc 是一家临床阶段的生物技术公司,利用其专有技术平台开发更安全的处方药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105223429a218c59f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105223429a218c59f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ENSC"],"gpt_icon":1},{"id":"2480818205","title":"Ensysce Biosciences, Inc.盘中异动 早盘股价大涨10.75%报0.720美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480818205","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480818205?lang=zh_cn&edition=full","pubTime":"2024-11-04 22:32","pubTimestamp":1730730740,"startTime":"0","endTime":"0","summary":"北京时间2024年11月04日22时32分,Ensysce Biosciences, Inc.股票出现异动,股价大幅上涨10.75%。截至发稿,该股报0.720美元/股,成交量421.023万股,换手率28.23%,振幅4.45%。Ensysce Biosciences, Inc.股票所在的生物技术行业中,整体涨幅为0.23%。Ensysce Biosciences, Inc.公司简介:Ensysce Biosciences Inc 是一家临床阶段的生物技术公司,利用其专有技术平台开发更安全的处方药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110422322095bdc9e6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110422322095bdc9e6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ENSC","BK4139"],"gpt_icon":1},{"id":"2480889343","title":"Ensysce Biosciences, Inc.盘中异动 股价大涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2480889343","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480889343?lang=zh_cn&edition=full","pubTime":"2024-11-01 21:32","pubTimestamp":1730467968,"startTime":"0","endTime":"0","summary":"北京时间2024年11月01日21时32分,Ensysce Biosciences, Inc.股票出现波动,股价急速拉升5.03%。Ensysce Biosciences, Inc.股票所在的生物技术行业中,整体涨幅为0.06%。其相关个股中,Tc Biopharm Plc C/Wts 10/02/2028 、Klotho Neurosciences Inc C/Wts 21/06/2029 、Theriva Biologics, Inc.涨幅较大,Theriva Biologics, Inc.、Athira Pharma, Inc.、Elevai Labs, Inc.较为活跃,换手率分别为1283.61%、110.91%、75.01%,振幅较大的相关个股有Cyclerion Therapeutics, Inc.、Mesoblast Ltd、Athira Pharma, Inc.,振幅分别为19.38%、18.08%、12.57%。Ensysce Biosciences, Inc.公司简介:Ensysce Biosciences Inc 是一家临床阶段的生物技术公司,利用其专有技术平台开发更安全的处方药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110121324895bdab1f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110121324895bdab1f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ENSC","BK4139"],"gpt_icon":0},{"id":"2479080267","title":"Ensysce Biosciences, Inc.盘中异动 早盘大幅下跌12.72%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479080267","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479080267?lang=zh_cn&edition=full","pubTime":"2024-10-31 21:32","pubTimestamp":1730381536,"startTime":"0","endTime":"0","summary":"北京时间2024年10月31日21时32分,Ensysce Biosciences, Inc.股票出现异动,股价快速跳水12.72%。Ensysce Biosciences, Inc.股票所在的生物技术行业中,整体跌幅为1.85%。其相关个股中,Aerovate Therapeutics, Inc.、180 Life Sciences Corp C/Wts 07/11/2025、Celularity Inc C/Wts 16/07/2026 涨幅较大,Evogene Ltd.、Aditxt, Inc.、Palisade Bio, Inc.较为活跃,换手率分别为191.24%、186.29%、145.77%,振幅较大的相关个股有180 Life Sciences Corp C/Wts 07/11/2025、Equillium, Inc.、Aerovate Therapeutics, Inc.,振幅分别为21.98%、14.49%、9.59%。Ensysce Biosciences, Inc.公司简介:Ensysce Biosciences Inc 是一家临床阶段的生物技术公司,利用其专有技术平台开发更安全的处方药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103121321695bd9c08&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103121321695bd9c08&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ENSC"],"gpt_icon":0},{"id":"2479223357","title":"Ensysce Biosciences, Inc.盘中异动 股价大涨5.17%报0.350美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479223357","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479223357?lang=zh_cn&edition=full","pubTime":"2024-10-30 00:01","pubTimestamp":1730217675,"startTime":"0","endTime":"0","summary":"北京时间2024年10月30日00时01分,Ensysce Biosciences, Inc.股票出现异动,股价急速拉升5.17%。Ensysce Biosciences, Inc.股票所在的生物技术行业中,整体跌幅为0.03%。其相关个股中,Glycomimetics, Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028、Klotho Neurosciences Inc C/Wts 21/06/2029 涨幅较大,Lixte Biotechnology Holdings, Inc.、Glycomimetics, Inc.、Novabay Pharmaceuticals, Inc.较为活跃,换手率分别为1292.83%、971.74%、313.66%,振幅较大的相关个股有Glycomimetics, Inc.、Cardio Diagnostics Holdings Inc C/Wts To Pur Com、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 ,振幅分别为160.88%、88.24%、65.41%。Ensysce Biosciences, Inc.公司简介:Ensysce Biosciences Inc 是一家临床阶段的生物技术公司,利用其专有技术平台开发更安全的处方药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103000011598e3f268&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103000011598e3f268&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ENSC","BK4139"],"gpt_icon":1},{"id":"2478291486","title":"Ensysce Biosciences, Inc.盘中异动 早盘股价大涨5.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478291486","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478291486?lang=zh_cn&edition=full","pubTime":"2024-10-28 21:40","pubTimestamp":1730122827,"startTime":"0","endTime":"0","summary":"北京时间2024年10月28日21时40分,Ensysce Biosciences, Inc.股票出现异动,股价大幅拉升5.34%。Ensysce Biosciences, Inc.股票所在的生物技术行业中,整体涨幅为0.34%。其相关个股中,Klotho Neurosciences Inc C/Wts 21/06/2029 、Monte Rosa Therapeutics, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大,Tc Biopharm Plc、Viracta Therapeutics, Inc.、Immunoprecise Antibodies Ltd.较为活跃,换手率分别为551.68%、49.00%、37.91%,振幅较大的相关个股有Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Monte Rosa Therapeutics, Inc.、Monopar Therapeutics Inc.,振幅分别为45.41%、20.45%、18.55%。Ensysce Biosciences, Inc.公司简介:Ensysce Biosciences Inc 是一家临床阶段的生物技术公司,利用其专有技术平台开发更安全的处方药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028214027971a2a38&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028214027971a2a38&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ENSC"],"gpt_icon":1},{"id":"2478693143","title":"Ensysce Biosciences, Inc.盘中异动 早盘快速上涨5.24%报0.332美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478693143","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478693143?lang=zh_cn&edition=full","pubTime":"2024-10-25 22:23","pubTimestamp":1729866219,"startTime":"0","endTime":"0","summary":"北京时间2024年10月25日22时23分,Ensysce Biosciences, Inc.股票出现异动,股价大幅拉升5.24%。Ensysce Biosciences, Inc.股票所在的生物技术行业中,整体涨幅为0.91%。其相关个股中,Qualigen Therapeutics, Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Elevai Labs, Inc.涨幅较大,180 Life Sciences Corp.、Elevai Labs, Inc.、Tc Biopharm Plc较为活跃,换手率分别为717.01%、652.37%、156.14%,振幅较大的相关个股有Qualigen Therapeutics, Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Elevai Labs, Inc.,振幅分别为91.58%、77.79%、69.41%。Ensysce Biosciences, Inc.公司简介:Ensysce Biosciences Inc 是一家临床阶段的生物技术公司,利用其专有技术平台开发更安全的处方药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102522233998e3e862&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102522233998e3e862&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4183","BK4139","ENSC","ELAB"],"gpt_icon":1},{"id":"2477313516","title":"Ensysce Biosciences, Inc.盘中异动 早盘股价大跌6.68%报0.374美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477313516","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477313516?lang=zh_cn&edition=full","pubTime":"2024-10-24 21:30","pubTimestamp":1729776624,"startTime":"0","endTime":"0","summary":"北京时间2024年10月24日21时30分,Ensysce Biosciences, Inc.股票出现异动,股价急速跳水6.68%。Ensysce Biosciences, Inc.股票所在的生物技术行业中,整体涨幅为0.00%。其相关个股中,Cns Pharmaceuticals, Inc.、Tevogen Bio Holdings Inc.、Chromocell Therapeutics Corporation涨幅较大,Qualigen Therapeutics, Inc.、Cns Pharmaceuticals, Inc.、Genprex, Inc.较为活跃,换手率分别为196.25%、90.35%、24.27%,振幅较大的相关个股有Qualigen Therapeutics, Inc.、Renovaro Inc.、Psyence Biomedical Ltd.,振幅分别为5.75%、4.65%、3.74%。Ensysce Biosciences, Inc.公司简介:Ensysce Biosciences Inc 是一家临床阶段的生物技术公司,利用其专有技术平台开发更安全的处方药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241024213025a1e7304e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241024213025a1e7304e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ENSC"],"gpt_icon":1},{"id":"2477538281","title":"Ensysce Biosciences, Inc.股价重挫22.08% 市值跌128.64万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477538281","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477538281?lang=zh_cn&edition=full","pubTime":"2024-10-23 21:32","pubTimestamp":1729690337,"startTime":"0","endTime":"0","summary":"北京时间2024年10月23日21时32分,Ensysce Biosciences, Inc.股票出现波动,股价急速跳水22.08%。Ensysce Biosciences, Inc.股票所在的生物技术行业中,整体跌幅为0.17%。其相关个股中,Cns Pharmaceuticals, Inc.、Virax Biolabs Group Limited、Dbv Technologies涨幅较大,Virax Biolabs Group Limited、Cns Pharmaceuticals, Inc.、Cyclacel Pharmaceuticals, Inc.较为活跃,换手率分别为899.36%、496.96%、272.43%,振幅较大的相关个股有Cns Pharmaceuticals, Inc.、Virax Biolabs Group Limited、Tevogen Bio Holdings Inc.,振幅分别为35.55%、22.02%、18.01%。Ensysce Biosciences, Inc.公司简介:Ensysce Biosciences Inc 是一家临床阶段的生物技术公司,利用其专有技术平台开发更安全的处方药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102321321895bd42e7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102321321895bd42e7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ENSC"],"gpt_icon":1},{"id":"2477778332","title":"Ensysce Biosciences, Inc.股价上涨155.92% 市值涨1140.24万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477778332","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477778332?lang=zh_cn&edition=full","pubTime":"2024-10-22 21:31","pubTimestamp":1729603861,"startTime":"0","endTime":"0","summary":"北京时间2024年10月22日21时31分,Ensysce Biosciences, Inc.股票出现波动,股价急速上涨155.92%。Ensysce Biosciences, Inc.股票所在的生物技术行业中,整体涨幅为0.00%。其相关个股中,Ensysce Biosciences, Inc.、Genprex, Inc.、Tc Biopharm Plc涨幅较大,Genprex, Inc.、Tc Biopharm Plc、Ensysce Biosciences, Inc.较为活跃,换手率分别为1698.44%、1118.45%、1016.89%,振幅较大的相关个股有Ensysce Biosciences, Inc.、Inmed Pharmaceuticals Inc.、Aptevo Therapeutics Inc.,振幅分别为14.17%、8.45%、6.78%。Ensysce Biosciences, Inc.公司简介:Ensysce Biosciences Inc 是一家临床阶段的生物技术公司,利用其专有技术平台开发更安全的处方药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102221310195bb6bda&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102221310195bb6bda&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ENSC"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ensysce.com","stockEarnings":[{"period":"1week","weight":-0.0681},{"period":"1month","weight":0.0991},{"period":"3month","weight":0.3436},{"period":"6month","weight":0.0393},{"period":"1year","weight":-0.3206},{"period":"ytd","weight":-0.4411}],"compareEarnings":[{"period":"1week","weight":0.0005},{"period":"1month","weight":0.0177},{"period":"3month","weight":0.0561},{"period":"6month","weight":0.1213},{"period":"1year","weight":0.3047},{"period":"ytd","weight":0.249}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Ensysce Biosciences, Inc.于2003年4月在特拉华州注册成立。该公司是一家临床阶段的生物技术公司,利用其专有技术平台开发更安全的处方药。利用其胰蛋白酶激活滥用保护和多药滥用抗性平台,该公司正在开发一类新的强大、防篡改的阿片类药物,可防止药物滥用和过量服用。预计Ensysce的产品将提供更安全的选择来治疗严重的疼痛,并有助于预防阿片类药物滥用造成的死亡,从而降低人力和经济成本。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.026078},{"month":2,"riseRate":0.166667,"avgChangeRate":-0.1585},{"month":3,"riseRate":0.428571,"avgChangeRate":-0.046294},{"month":4,"riseRate":0.142857,"avgChangeRate":-0.084407},{"month":5,"riseRate":0.571429,"avgChangeRate":-0.105309},{"month":6,"riseRate":0.714286,"avgChangeRate":0.045519},{"month":7,"riseRate":0.428571,"avgChangeRate":-0.157989},{"month":8,"riseRate":0.285714,"avgChangeRate":-0.117865},{"month":9,"riseRate":0.428571,"avgChangeRate":-0.16395},{"month":10,"riseRate":0.428571,"avgChangeRate":0.079948},{"month":11,"riseRate":0.714286,"avgChangeRate":-0.011331},{"month":12,"riseRate":0.666667,"avgChangeRate":0.215166}],"exchange":"NASDAQ","name":"Ensysce Biosciences Inc.","nameEN":"Ensysce Biosciences Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Ensysce Biosciences Inc.(ENSC)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Ensysce Biosciences Inc.(ENSC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Ensysce Biosciences Inc.,ENSC,Ensysce Biosciences Inc.股票,Ensysce Biosciences Inc.股票老虎,Ensysce Biosciences Inc.股票老虎国际,Ensysce Biosciences Inc.行情,Ensysce Biosciences Inc.股票行情,Ensysce Biosciences Inc.股价,Ensysce Biosciences Inc.股市,Ensysce Biosciences Inc.股票价格,Ensysce Biosciences Inc.股票交易,Ensysce Biosciences Inc.股票购买,Ensysce Biosciences Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Ensysce Biosciences Inc.(ENSC)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Ensysce Biosciences Inc.(ENSC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}